Kiersten Stead is a highly qualified expert, working in Pairwise Plants main office of which is in 416. as a Board Member and Co-Founder from 2017. Kiersten has earned professional experience in more than 16 positions at various companies. Kiersten Stead went to the University of Alberta and received education from 2009 to 2011. San Francisco, California is the area, where this professional was known to be situated. This expert's email address and phone can be easily accessed through this website by request.
Name variants:
Kiersten Stead
Contact Information
Last Update
Jul 4, 2022
Email
ks**@ualberta.ca, ki**@monsanto.com
Location
San Francisco, CA
Company
Pairwise Plants
Workplace
Board Member and Co-Founder
Work History
Board Member and Co-Founder
807 east Main St SUITE 4-100, Durham, NC 27701
Apr 2017 — Oct 2018
Board Observer
605 west California Ave, Sunnyvale, CA 94086
Blue River Technology serves farmers with revolutionary computer-vision based robotics that unlock greater yield potential. Our proprietary systems identify key characteristics about every p...
Jan 2015 — Sep 2017
Venture Capital
San Francisco, CA
Burrill & Company has $1.5B under management and invests in industrial biotechnology and life science companies whose technologies and products are applicable across a wide range of industry...
May 2011 — Oct 2013
Business Development Associate
Business Development and Tech Transfer in Agriculture, Nanotechnology and Engineering
May 2010 — May 2011
Research Associate
Agricultural Biotechnology, Plant Genetics, Oilseeds, Canola
May 2009 — May 2010
Post-Doc
Agricultural Biotechnology
Management
Research
Bioactive oils
Teaching
2007 — 2009
Education
2009 — 2011
1999 — 2006
1993 — 1997
Occupations
Executive
Managing Partner
Board Member
Co-Founder
Partner
Chief Executive
Management Team Executive
Operations Manager
Founder
Skills
Biotechnology
Venture Capital
Business Development
Lifesciences
Technology Transfer
Life Sciences
Start Ups
Strategy
Cleantech
Private Equity
Entrepreneurship
Agriculture
Commercialization
Nanotechnology
Mergers and Acquisitions
Research
Investment Banking
Molecular Biology
R&D
Market Analysis
Genomics
Valuation
Investments
Corporate Development
Finance
Pharmaceutical Industry
Patents
Medical Devices
Due Diligence
Drug Discovery